irinotecan has been researched along with sulfur dioxide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Feng, C; Huang, X; Li, R; Lu, G | 1 |
Li, Y; Qu, J; Zhang, P; Zhang, Z | 1 |
He, P; Liu, X; Xiao, C; Yi, X; Zhang, H; Zhang, Y | 1 |
3 other study(ies) available for irinotecan and sulfur dioxide
Article | Year |
---|---|
Sulfur dioxide signaling molecule-responsive polymeric nanoparticles.
Topics: Drug Liberation; Irinotecan; Levulinic Acids; Micelles; Nanoparticles; Polymers; Signal Transduction; Sulfur Dioxide; Topoisomerase I Inhibitors | 2020 |
Reduction-responsive sulfur dioxide polymer prodrug nanoparticles loaded with irinotecan for combination osteosarcoma therapy.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Female; Humans; Irinotecan; Mice, Inbred BALB C; Micelles; Nanoparticles; Osteosarcoma; Oxidation-Reduction; Polymers; Prodrugs; Sulfur Dioxide; Topoisomerase I Inhibitors | 2020 |
A PEGylated alternating copolymeric prodrug of sulfur dioxide with glutathione responsiveness for Irinotecan delivery.
Topics: Dose-Response Relationship, Drug; Drug Delivery Systems; Glutathione; Hep G2 Cells; Humans; Irinotecan; Nuclear Magnetic Resonance, Biomolecular; Polyethylene Glycols; Polymers; Prodrugs; Sulfur Dioxide | 2021 |